Blais A, Lan A, Blachier F, Benamouzig R, Jouet P, Couvineau A
Int J Mol Sci. 2023; 24(11).
PMID: 37298505
PMC: 10253642.
DOI: 10.3390/ijms24119554.
Igarashi S, Nozu T, Ishioh M, Funayama T, Sumi C, Saito T
J Physiol Biochem. 2023; 79(3):625-634.
PMID: 37099079
DOI: 10.1007/s13105-023-00962-4.
Jo J, Kim J, Leem J
J Clin Med. 2022; 11(23).
PMID: 36498769
PMC: 9740499.
DOI: 10.3390/jcm11237196.
Abdelmissih S
Cureus. 2022; 14(10):e30788.
PMID: 36457603
PMC: 9705054.
DOI: 10.7759/cureus.30788.
Couvineau A, Nicole P, Gratio V, Voisin T
Front Endocrinol (Lausanne). 2022; 13:931970.
PMID: 35966051
PMC: 9365956.
DOI: 10.3389/fendo.2022.931970.
The ability of orexin-A to modify pain-induced cyclooxygenase-2 and brain-derived neurotrophic factor expression is associated with its ability to inhibit capsaicin-induced pulpal nociception in rats.
Shahsavari F, Abbasnejad M, Esmaeili-Mahani S, Raoof M
Korean J Pain. 2022; 35(3):261-270.
PMID: 35768981
PMC: 9251390.
DOI: 10.3344/kjp.2022.35.3.261.
Reduced CSF orexin levels in rats and patients with systemic inflammation: a preliminary study.
Ogawa Y, Shimojo N, Ishii A, Tamaoka A, Kawano S, Inoue Y
BMC Res Notes. 2022; 15(1):221.
PMID: 35752867
PMC: 9233848.
DOI: 10.1186/s13104-022-06121-0.
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.
Couvineau A, Voisin T, Nicole P, Gratio V, Blais A
World J Gastroenterol. 2021; 27(44):7582-7596.
PMID: 34908800
PMC: 8641057.
DOI: 10.3748/wjg.v27.i44.7582.
Case Report: Reduced CSF Orexin Levels in a Patient With Sepsis.
Ogawa Y, Ezaki S, Shimojo N, Kawano S
Front Neurosci. 2021; 15:739323.
PMID: 34690677
PMC: 8526783.
DOI: 10.3389/fnins.2021.739323.
Histamine in murine narcolepsy: What do genetic and immune models tell us?.
Melzi S, Morel A, Scote-Blachon C, Liblau R, Dauvilliers Y, Peyron C
Brain Pathol. 2021; 32(2):e13027.
PMID: 34672414
PMC: 8877734.
DOI: 10.1111/bpa.13027.
Treatment with Histone Deacetylase Inhibitor Attenuates Peripheral Inflammation-Induced Cognitive Dysfunction and Microglial Activation: The Effect of SAHA as a Peripheral HDAC Inhibitor.
Takada N, Nakamura Y, Ikeda K, Takaoka N, Hisaoka-Nakashima K, Sanoh S
Neurochem Res. 2021; 46(9):2285-2296.
PMID: 34081246
DOI: 10.1007/s11064-021-03367-1.
Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity.
Mogavero M, Silvani A, DelRosso L, Salemi M, Ferri R
Cancers (Basel). 2021; 13(11).
PMID: 34073579
PMC: 8198883.
DOI: 10.3390/cancers13112612.
Intranasal insulin and orexins to treat age-related cognitive decline.
Erichsen J, Calva C, Reagan L, Fadel J
Physiol Behav. 2021; 234:113370.
PMID: 33621561
PMC: 8053680.
DOI: 10.1016/j.physbeh.2021.113370.
Differential Thermoregulatory and Inflammatory Patterns in the Circadian Response to LPS-Induced Septic Shock.
Mul Fedele M, Aiello I, Caldart C, Golombek D, Marpegan L, Paladino N
Front Cell Infect Microbiol. 2020; 10:100.
PMID: 32226779
PMC: 7080817.
DOI: 10.3389/fcimb.2020.00100.
Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice.
Mittra I, Pal K, Pancholi N, Tidke P, Siddiqui S, Rane B
PLoS One. 2020; 15(3):e0229017.
PMID: 32130239
PMC: 7055819.
DOI: 10.1371/journal.pone.0229017.
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases.
Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan Y
Front Endocrinol (Lausanne). 2019; 10:709.
PMID: 31695678
PMC: 6817618.
DOI: 10.3389/fendo.2019.00709.
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G
J Neuroinflammation. 2019; 16(1):64.
PMID: 30894198
PMC: 6425555.
DOI: 10.1186/s12974-019-1447-y.
High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss.
Duffy C, Hofmeister J, Nixon J, Butterick T
Neurobiol Learn Mem. 2018; 157:41-47.
PMID: 30471346
PMC: 6547825.
DOI: 10.1016/j.nlm.2018.11.008.
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role.
Couvineau A, Dayot S, Nicole P, Gratio V, Rebours V, Couvelard A
Front Endocrinol (Lausanne). 2018; 9:573.
PMID: 30319552
PMC: 6170602.
DOI: 10.3389/fendo.2018.00573.
Hypocretin as a Hub for Arousal and Motivation.
Tyree S, Borniger J, De Lecea L
Front Neurol. 2018; 9:413.
PMID: 29928253
PMC: 5997825.
DOI: 10.3389/fneur.2018.00413.